Acadian Asset Management
CBAY

Acadian Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Acadian Asset Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31,827
Closed -$94K – 1900
2022
Q2 		$94K Buy
+31,827
New +$76K ﹤0.01% 1370
2020
Q2 		– Sell
-611,297
Closed -$906K – 2371
2020
Q1 		$906K Buy
611,297
+198,002
+48% +$332K 0.01% 825
2019
Q4 		$810K Buy
+413,295
New +$1.55M ﹤0.01% 936
2018
Q2 		– Sell
-33,802
Closed -$439K – 1884
2018
Q1 		$439K Buy
+33,802
New +$420K ﹤0.01% 891
2017
Q2 		– Sell
-29,969
Closed -$129K – 1632
2017
Q1 		$129K Buy
+29,969
New +$86K ﹤0.01% 1101
2015
Q2 		– Sell
-30,383
Closed -$211K – 1528
2015
Q1 		$211K Buy
+30,383
New +$292K ﹤0.01% 914

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM